ACIU
AC Immune S.A.
NASDAQ · CHHealthcareBiotechnology
$2.25+2.27%
Price as of Jul 20, 2026
ACIU capital
AC Immune S.A. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.14x
- Net debt / equity
- -0.47x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 0.23x
Liquidity & coverage
- Current ratio
- 0.87x
- Quick ratio
- 0.87x
- Cash ratio
- 0.81x
- Interest coverage
- -413.25x
- EBITDA / interest
- -411.32x
- Working capital
- -$15.1M
Cash & dividend
- FCF / debt
- -11.83x
- Cash flow / debt
- -11.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.